HER2抗体の世界市場（～2026年）

• 英文タイトル：Global HER2 Antibodies Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY12175
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、90ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料はHER2抗体のグローバル市場について調査・分析したレポートです。種類別（トラスツズマブ、ラパチニブ、アド-トラスツズマブエムタンシン、ペルツズマブ、エベロリムス）市場規模、用途別（病院薬局、小売薬局、Eコマース）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別HER2抗体の競争状況、市場シェア
・世界のHER2抗体市場：種類別市場規模 2015年-2020年（トラスツズマブ、ラパチニブ、アド-トラスツズマブエムタンシン、ペルツズマブ、エベロリムス）
・世界のHER2抗体市場：種類別市場規模予測 2021年-2026年（トラスツズマブ、ラパチニブ、アド-トラスツズマブエムタンシン、ペルツズマブ、エベロリムス）
・世界のHER2抗体市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、Eコマース）
・世界のHER2抗体市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、Eコマース）
・北米のHER2抗体市場分析：米国、カナダ
・ヨーロッパのHER2抗体市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのHER2抗体市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のHER2抗体市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのHER2抗体市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Novartis、Pfizer、Roche、Abnova、InvivoGen、Celltrion、Biocon、Novus Biologicals
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

The demand of HER2 Antibodies is increasing, and primarily gaining from growing awareness regarding the prevalence of HER2 positive breast cancer.

Market Analysis and Insights: Global HER2 Antibodies Market
The global HER2 Antibodies market size is projected to reach US$ 8543.4 million by 2026, from US$ 8106.1 million in 2020, at a CAGR of 5.0%% during 2021-2026.

Global HER2 Antibodies Scope and Market Size
HER2 Antibodies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global HER2 Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Novartis
Pfizer
Roche
Abnova
InvivoGen
Celltrion
Biocon
Novus Biologicals

Market segment by Type, the product can be split into
Trastuzumab
Lapatinib
Ado-trastuzumab emtansine
Pertuzumab
Everolimus
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
E-commerce

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by HER2 Antibodies Revenue
1.4 Market by Type
1.4.1 Global HER2 Antibodies Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Trastuzumab
1.4.3 Lapatinib
1.4.4 Ado-trastuzumab emtansine
1.4.5 Pertuzumab
1.4.6 Everolimus
1.5 Market by Application
1.5.1 Global HER2 Antibodies Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 E-commerce
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global HER2 Antibodies Market Perspective (2015-2026)
2.2 Global HER2 Antibodies Growth Trends by Regions
2.2.1 HER2 Antibodies Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 HER2 Antibodies Historic Market Share by Regions (2015-2020)
2.2.3 HER2 Antibodies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 HER2 Antibodies Market Growth Strategy
2.3.6 Primary Interviews with Key HER2 Antibodies Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top HER2 Antibodies Players by Market Size
3.1.1 Global Top HER2 Antibodies Players by Revenue (2015-2020)
3.1.2 Global HER2 Antibodies Revenue Market Share by Players (2015-2020)
3.1.3 Global HER2 Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global HER2 Antibodies Market Concentration Ratio
3.2.1 Global HER2 Antibodies Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by HER2 Antibodies Revenue in 2019
3.3 HER2 Antibodies Key Players Head office and Area Served
3.4 Key Players HER2 Antibodies Product Solution and Service
3.5 Date of Enter into HER2 Antibodies Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global HER2 Antibodies Historic Market Size by Type (2015-2020)
4.2 Global HER2 Antibodies Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global HER2 Antibodies Market Size by Application (2015-2020)
5.2 Global HER2 Antibodies Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America HER2 Antibodies Market Size (2015-2020)
6.2 HER2 Antibodies Key Players in North America (2019-2020)
6.3 North America HER2 Antibodies Market Size by Type (2015-2020)
6.4 North America HER2 Antibodies Market Size by Application (2015-2020)

7 Europe
7.1 Europe HER2 Antibodies Market Size (2015-2020)
7.2 HER2 Antibodies Key Players in Europe (2019-2020)
7.3 Europe HER2 Antibodies Market Size by Type (2015-2020)
7.4 Europe HER2 Antibodies Market Size by Application (2015-2020)

8 China
8.1 China HER2 Antibodies Market Size (2015-2020)
8.2 HER2 Antibodies Key Players in China (2019-2020)
8.3 China HER2 Antibodies Market Size by Type (2015-2020)
8.4 China HER2 Antibodies Market Size by Application (2015-2020)

9 Japan
9.1 Japan HER2 Antibodies Market Size (2015-2020)
9.2 HER2 Antibodies Key Players in Japan (2019-2020)
9.3 Japan HER2 Antibodies Market Size by Type (2015-2020)
9.4 Japan HER2 Antibodies Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia HER2 Antibodies Market Size (2015-2020)
10.2 HER2 Antibodies Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia HER2 Antibodies Market Size by Type (2015-2020)
10.4 Southeast Asia HER2 Antibodies Market Size by Application (2015-2020)

11 India
11.1 India HER2 Antibodies Market Size (2015-2020)
11.2 HER2 Antibodies Key Players in India (2019-2020)
11.3 India HER2 Antibodies Market Size by Type (2015-2020)
11.4 India HER2 Antibodies Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America HER2 Antibodies Market Size (2015-2020)
12.2 HER2 Antibodies Key Players in Central & South America (2019-2020)
12.3 Central & South America HER2 Antibodies Market Size by Type (2015-2020)
12.4 Central & South America HER2 Antibodies Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Novartis
13.1.1 Novartis Company Details
13.1.2 Novartis Business Overview
13.1.3 Novartis HER2 Antibodies Introduction
13.1.4 Novartis Revenue in HER2 Antibodies Business (2015-2020))
13.1.5 Novartis Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer HER2 Antibodies Introduction
13.2.4 Pfizer Revenue in HER2 Antibodies Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Roche
13.3.1 Roche Company Details
13.3.2 Roche Business Overview
13.3.3 Roche HER2 Antibodies Introduction
13.3.4 Roche Revenue in HER2 Antibodies Business (2015-2020)
13.3.5 Roche Recent Development
13.4 Abnova
13.4.1 Abnova Company Details
13.4.2 Abnova Business Overview
13.4.3 Abnova HER2 Antibodies Introduction
13.4.4 Abnova Revenue in HER2 Antibodies Business (2015-2020)
13.4.5 Abnova Recent Development
13.5 InvivoGen
13.5.1 InvivoGen Company Details
13.5.2 InvivoGen Business Overview
13.5.3 InvivoGen HER2 Antibodies Introduction
13.5.4 InvivoGen Revenue in HER2 Antibodies Business (2015-2020)
13.5.5 InvivoGen Recent Development
13.6 Celltrion
13.6.1 Celltrion Company Details
13.6.2 Celltrion Business Overview
13.6.3 Celltrion HER2 Antibodies Introduction
13.6.4 Celltrion Revenue in HER2 Antibodies Business (2015-2020)
13.6.5 Celltrion Recent Development
13.7 Biocon
13.7.1 Biocon Company Details
13.7.2 Biocon Business Overview
13.7.3 Biocon HER2 Antibodies Introduction
13.7.4 Biocon Revenue in HER2 Antibodies Business (2015-2020)
13.7.5 Biocon Recent Development
13.8 Novus Biologicals
13.8.1 Novus Biologicals Company Details
13.8.2 Novus Biologicals Business Overview
13.8.3 Novus Biologicals HER2 Antibodies Introduction
13.8.4 Novus Biologicals Revenue in HER2 Antibodies Business (2015-2020)
13.8.5 Novus Biologicals Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. HER2 Antibodies Key Market Segments
Table 2. Key Players Covered: Ranking by HER2 Antibodies Revenue
Table 3. Ranking of Global Top HER2 Antibodies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global HER2 Antibodies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Trastuzumab
Table 6. Key Players of Lapatinib
Table 7. Key Players of Ado-trastuzumab emtansine
Table 8. Key Players of Pertuzumab
Table 9. Key Players of Everolimus
Table 10. Global HER2 Antibodies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global HER2 Antibodies Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global HER2 Antibodies Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global HER2 Antibodies Market Share by Regions (2015-2020)
Table 14. Global HER2 Antibodies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global HER2 Antibodies Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. HER2 Antibodies Market Growth Strategy
Table 20. Main Points Interviewed from Key HER2 Antibodies Players
Table 21. Global HER2 Antibodies Revenue by Players (2015-2020) (Million US$)
Table 22. Global HER2 Antibodies Market Share by Players (2015-2020)
Table 23. Global Top HER2 Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HER2 Antibodies as of 2019)
Table 24. Global HER2 Antibodies by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players HER2 Antibodies Product Solution and Service
Table 27. Date of Enter into HER2 Antibodies Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global HER2 Antibodies Market Size by Type (2015-2020) (Million US$)
Table 30. Global HER2 Antibodies Market Size Share by Type (2015-2020)
Table 31. Global HER2 Antibodies Revenue Market Share by Type (2021-2026)
Table 32. Global HER2 Antibodies Market Size Share by Application (2015-2020)
Table 33. Global HER2 Antibodies Market Size by Application (2015-2020) (Million US$)
Table 34. Global HER2 Antibodies Market Size Share by Application (2021-2026)
Table 35. North America Key Players HER2 Antibodies Revenue (2019-2020) (Million US$)
Table 36. North America Key Players HER2 Antibodies Market Share (2019-2020)
Table 37. North America HER2 Antibodies Market Size by Type (2015-2020) (Million US$)
Table 38. North America HER2 Antibodies Market Share by Type (2015-2020)
Table 39. North America HER2 Antibodies Market Size by Application (2015-2020) (Million US$)
Table 40. North America HER2 Antibodies Market Share by Application (2015-2020)
Table 41. Europe Key Players HER2 Antibodies Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players HER2 Antibodies Market Share (2019-2020)
Table 43. Europe HER2 Antibodies Market Size by Type (2015-2020) (Million US$)
Table 44. Europe HER2 Antibodies Market Share by Type (2015-2020)
Table 45. Europe HER2 Antibodies Market Size by Application (2015-2020) (Million US$)
Table 46. Europe HER2 Antibodies Market Share by Application (2015-2020)
Table 47. China Key Players HER2 Antibodies Revenue (2019-2020) (Million US$)
Table 48. China Key Players HER2 Antibodies Market Share (2019-2020)
Table 49. China HER2 Antibodies Market Size by Type (2015-2020) (Million US$)
Table 50. China HER2 Antibodies Market Share by Type (2015-2020)
Table 51. China HER2 Antibodies Market Size by Application (2015-2020) (Million US$)
Table 52. China HER2 Antibodies Market Share by Application (2015-2020)
Table 53. Japan Key Players HER2 Antibodies Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players HER2 Antibodies Market Share (2019-2020)
Table 55. Japan HER2 Antibodies Market Size by Type (2015-2020) (Million US$)
Table 56. Japan HER2 Antibodies Market Share by Type (2015-2020)
Table 57. Japan HER2 Antibodies Market Size by Application (2015-2020) (Million US$)
Table 58. Japan HER2 Antibodies Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players HER2 Antibodies Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players HER2 Antibodies Market Share (2019-2020)
Table 61. Southeast Asia HER2 Antibodies Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia HER2 Antibodies Market Share by Type (2015-2020)
Table 63. Southeast Asia HER2 Antibodies Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia HER2 Antibodies Market Share by Application (2015-2020)
Table 65. India Key Players HER2 Antibodies Revenue (2019-2020) (Million US$)
Table 66. India Key Players HER2 Antibodies Market Share (2019-2020)
Table 67. India HER2 Antibodies Market Size by Type (2015-2020) (Million US$)
Table 68. India HER2 Antibodies Market Share by Type (2015-2020)
Table 69. India HER2 Antibodies Market Size by Application (2015-2020) (Million US$)
Table 70. India HER2 Antibodies Market Share by Application (2015-2020)
Table 71. Central & South America Key Players HER2 Antibodies Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players HER2 Antibodies Market Share (2019-2020)
Table 73. Central & South America HER2 Antibodies Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America HER2 Antibodies Market Share by Type (2015-2020)
Table 75. Central & South America HER2 Antibodies Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America HER2 Antibodies Market Share by Application (2015-2020)
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Product
Table 80. Novartis Revenue in HER2 Antibodies Business (2015-2020) (Million US$)
Table 81. Novartis Recent Development
Table 82. Pfizer Company Details
Table 83. Pfizer Business Overview
Table 84. Pfizer Product
Table 85. Pfizer Revenue in HER2 Antibodies Business (2015-2020) (Million US$)
Table 86. Pfizer Recent Development
Table 87. Roche Company Details
Table 88. Roche Business Overview
Table 89. Roche Product
Table 90. Roche Revenue in HER2 Antibodies Business (2015-2020) (Million US$)
Table 91. Roche Recent Development
Table 92. Abnova Company Details
Table 93. Abnova Business Overview
Table 94. Abnova Product
Table 95. Abnova Revenue in HER2 Antibodies Business (2015-2020) (Million US$)
Table 96. Abnova Recent Development
Table 97. InvivoGen Company Details
Table 98. InvivoGen Business Overview
Table 99. InvivoGen Product
Table 100. InvivoGen Revenue in HER2 Antibodies Business (2015-2020) (Million US$)
Table 101. InvivoGen Recent Development
Table 102. Celltrion Company Details
Table 103. Celltrion Business Overview
Table 104. Celltrion Product
Table 105. Celltrion Revenue in HER2 Antibodies Business (2015-2020) (Million US$)
Table 106. Celltrion Recent Development
Table 107. Biocon Company Details
Table 108. Biocon Business Overview
Table 109. Biocon Product
Table 110. Biocon Revenue in HER2 Antibodies Business (2015-2020) (Million US$)
Table 111. Biocon Recent Development
Table 112. Novus Biologicals Business Overview
Table 113. Novus Biologicals Product
Table 114. Novus Biologicals Company Details
Table 115. Novus Biologicals Revenue in HER2 Antibodies Business (2015-2020) (Million US$)
Table 116. Novus Biologicals Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HER2 Antibodies Market Share by Type: 2020 VS 2026
Figure 2. Trastuzumab Features
Figure 3. Lapatinib Features
Figure 4. Ado-trastuzumab emtansine Features
Figure 5. Pertuzumab Features
Figure 6. Everolimus Features
Figure 7. Global HER2 Antibodies Market Share by Application: 2020 VS 2026
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. E-commerce Case Studies
Figure 11. HER2 Antibodies Report Years Considered
Figure 12. Global HER2 Antibodies Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global HER2 Antibodies Market Share by Regions: 2020 VS 2026
Figure 14. Global HER2 Antibodies Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global HER2 Antibodies Market Share by Players in 2019
Figure 17. Global Top HER2 Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HER2 Antibodies as of 2019
Figure 18. The Top 10 and 5 Players Market Share by HER2 Antibodies Revenue in 2019
Figure 19. North America HER2 Antibodies Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe HER2 Antibodies Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China HER2 Antibodies Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan HER2 Antibodies Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia HER2 Antibodies Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India HER2 Antibodies Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America HER2 Antibodies Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed

以下、関連資料のご紹介

HER2陰性乳がん治療の世界市場（～2026年）

Global HER2-negative breast cancer Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12176 2020年11月25日 97Pages
当調査資料はHER2陰性乳がん治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、手術、放射線、ホルモン療法/内分泌療法）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国...

診断用特殊抗体の世界市場（～2026年）

Global Diagnostic Specialty Antibodies Market Size, Status and Forecast 2020-2026
MRC2-11QY11641 2020年11月25日 92Pages
当調査資料は診断用特殊抗体のグローバル市場について調査・分析したレポートです。種類別（モノクローナル抗体、ポリクローナル抗体、組換えポリクローナル抗体）市場規模、用途別（病院、診断研究所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、...

治療用組換え抗体・タンパク質の世界市場（～2026年）

Global Recombinant Therapeutic Antibodies and Proteins Market Size, Status and Forecast 2020-2026
MRC2-11QY04472 2020年11月20日 91Pages
当調査資料は治療用組換え抗体・タンパク質のグローバル市場について調査・分析したレポートです。種類別（血漿たんぱく質、融合たんぱく質、モノクローナル抗体、ホルモン、酵素、凝固因子、その他）市場規模、用途別（腫瘍学、血液学、免疫学、内分泌学、感染症、心血管疾患、その他）市場規模、地域別（北米、米国、カナ...

モノクローナル抗体(mAb)バイオシミラーの世界市場（～2026年）

Global Monoclonal antibodies (mAbs) Biosimilars Market Size, Status and Forecast 2020-2026
MRC2-11QY03843 2020年11月20日 90Pages
当調査資料はモノクローナル抗体(mAb)バイオシミラーのグローバル市場について調査・分析したレポートです。種類別（エリスロポエチン（EPO）、ヒト成長ホルモン（HGH）、顆粒球コロニー刺激因子（G-CSF）、モノクローナル抗体（mAb）、インスリン、インターフェロン（IFN）、その他）市場規模、用途...

神経科学抗体・アッセイの世界市場（～2026年）

Global Neuroscience Antibodies and Assays Market Size, Status and Forecast 2020-2026
MRC2-11QY03959 2020年11月20日 95Pages
当調査資料は神経科学抗体・アッセイのグローバル市場について調査・分析したレポートです。種類別（消耗品、機器）市場規模、用途別（製薬・バイオテクノロジー企業、学術・研究所、病院・診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、...

抗体の世界市場（～2026年）

Global Antibodies Market Insights and Forecast to 2026
MRC2-11QY02522 2020年11月20日 110Pages
当調査資料は抗体のグローバル市場について調査・分析したレポートです。種類別（モノクローナル抗体、ポリクローナル抗体、抗体薬物複合体）市場規模、用途別（病院、介護施設、研究機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イ...

癌治療用モノクローナル抗体の世界市場（～2026年）

Global Cancer Monoclonal Antibodies Market Insights and Forecast to 2026
MRC2-11QY03648 2020年11月20日 115Pages
当調査資料は癌治療用モノクローナル抗体のグローバル市場について調査・分析したレポートです。種類別（マウス抗体、キメラ・ヒト化抗体、完全ヒト化抗体、その他）市場規模、用途別（肝臓、乳房、血液、脳、ホジキンリンパ腫・非ホジキンリンパ腫、結腸直腸、白血病、その他）市場規模、地域別（北米、米国、カナダ、ヨー...

乳癌モノクローナル抗体の世界市場（～2026年）

Global Breast Cancer Monoclonal Antibodies Market Size, Status and Forecast 2020-2026
MRC2-11QY11192 2020年11月25日 125Pages
当調査資料は乳癌モノクローナル抗体のグローバル市場について調査・分析したレポートです。種類別（ネイキッドMAb、コンジュゲートMAb）市場規模、用途別（病院、小売薬局、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イ...

C1GLT抗体の世界市場（～2026年）

Global C1GLT Antibody Market Insights and Forecast to 2026
MRC2-11QY03560 2020年11月20日 117Pages
当調査資料はC1GLT抗体のグローバル市場について調査・分析したレポートです。種類別（pAbs、mAb）市場規模、用途別（バイオサイエンス企業、病院・診療所、大学・機関、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、...

B4GN4抗体の世界市場（～2026年）

Global B4GN4 Antibody Market Insights and Forecast to 2026
MRC2-11QY02822 2020年11月20日 114Pages
当調査資料はB4GN4抗体のグローバル市場について調査・分析したレポートです。種類別（pAbs、mAb）市場規模、用途別（バイオサイエンス企業、病院・診療所、大学・機関、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、...

HER2陰性乳がん治療の世界市場（～2026年） HER2 (human epidermal growth factor receptor 2) is a protein that appears on the surface of some breast cancer cells. It may also be called HER2/neu or ErbB2.HER2-negative breast cancer means that the people have little or no HER2 protein. Market Analysis and Insights: Global HER2-negative breast ca…
診断用特殊抗体の世界市場（～2026年） Market Analysis and Insights: Global Diagnostic Specialty Antibodies Market The global Diagnostic Specialty Antibodies market size is projected to reach US$ 20750 million by 2026, from US$ 20090 million in 2020, at a CAGR of 3.0%% during 2021-2026. Global Diagnostic Specialty Antibodies Scope and Ma…
治療用組換え抗体・タンパク質の世界市場（～2026年） Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specific…
モノクローナル抗体(mAb)バイオシミラーの世界市場（～2026年） A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are “equivalent” in terms of q…
乳癌モノクローナル抗体の世界市場（～2026年） Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer. The HER-2 protein, present on the surface of normal breast cells, affects the growth of the malignant cells. The uncontrolled synthesis of this protei…